NSW has opened applications for a $20 million emerging technologies commercialisation fund, with $7 million available in the first round.
The fund targets what Innovation Minister Anoulack Chanthivong calls "the well-known gap in the innovation pipeline": the stage where startups have early product evidence but need capital to become investable.
Translation: this sits between friends and family money and Series A. The companies that hit this stage often have initial customer validation but need funding to build the sales motion that attracts proper VC interest.
The fund launched at Greenhouse, Sydney's climate tech hub, and forms part of the state's Innovation Blueprint. Applications are open now through Investment NSW.
What this means for ANZ sales teams
Government funding usually comes with conditions: reporting requirements, milestones, sometimes matching fund obligations. But for early-stage tech companies, it can mean the difference between building a proper sales team or limping along with founder-led sales.
Expect to see some of these funded companies start hiring their first commercial roles in Q3-Q4 2026. Typically 1-2 AEs, maybe an SDR if they are targeting enterprise. Base will likely sit below market rate with equity heavy comp structures.
The fund also announced bioscience startup grants, though specific recipients and amounts were not disclosed in the announcement.
The reality check
Government-backed commercialisation funds have a mixed track record. Some companies use them to build genuine revenue engines. Others burn through the cash on product development and still cannot sell.
If you are considering joining a company funded through this programme, ask: what is the path to revenue after this funding runs out? Who is buying, and why? Government money buys time, but it does not build GTM strategy.
Applications are open now through Investment NSW. No closing date announced yet.